F. Cabanillas

发表

Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma.

S. Jagannath, S. Tucker, W. Velasquez, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A predictive model for aggressive non-Hodgkin's lymphoma.

Emili Montserrat, Christian Gisselbrecht, Carlo Tondini, 1993, The New England journal of medicine.

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

R. Levy, M. Czuczman, A. Ho, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aggressive Non-Hodgkin ’ s Lymphomas in Immunocompromised

B. Barlogie, F. Cabanillas, E. Hersh, 2005 .

A review and interpretation of cytogenetic abnormalities identified in Hodgkin's disease

F. Cabanillas, F. Cabanillas, 1988, Hematological oncology.

Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy

P. Mclaughlin, F. Cabanillas, J. Cox, 2003, Cancer.

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.

R. Kurzrock, F. Cabanillas, M. Talpaz, 1993, Cancer research.

Serum Interleukin 6 Levels Are Elevated in Lymphoma Patients and Correlate with Survival in Advanced Hodgkin ' s Disease and with B Symptoms 1

R. Kurzrock, F. Cabanillas, M. Talpaz, 1993 .

Distribution of technetium-99m-labeled multilamellar liposomes in patients with Hodgkin's disease.

R. Perez-soler, F. Cabanillas, E. Hersh, 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Monitoring Follicular Lymphoma by Polymerase Chain Reaction

F. Cabanillas, Ming‐Sheng Lee, Ming-Sheng Lee, 2003 .

Treatment of elderly patients with glioblastoma

F. Cabanillas, 2012 .

Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors.

T. McDonnell, F. Cabanillas, G. Rassidakis, 2002, The American journal of pathology.

Primary hepatic lymphoma

L. North, F. Cabanillas, B. Osborne, 2001, Cancer.

HLA class II antigen associated invariant chain gene expression in malignant lymphoma

F. Cabanillas, G. Saunders, F. Narni, 1987, British journal of haematology.

Diffuse large-cell lymphoma. Part II: management.

F. Cabanillas, María V García-Pallas, Rafael D Betancourt-García, 2009, Puerto Rico health sciences journal.

Philadelphia chromosome without breakpoint cluster region rearrangement in a case of Lennert's lymphoma of suppressor phenotype

J. Manning, F. Cabanillas, J. Trujillo, 1989, Hematological oncology.

The Clinical Behavior of Localized and Multicentric Castleman Disease

J. Herrada, J. Manning, F. Cabanillas, 1998, Annals of Internal Medicine.

Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease.

W. Velasquez, L. Fuller, P. Mclaughlin, 1992, International journal of radiation oncology, biology, physics.

Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.

S. Tucker, W. Velasquez, P. Mclaughlin, 1991, Annals of internal medicine.

Molecular Response of Follicular Lymphoma to Cyclophosphamide, Doxorubicin, Vincristine, Prednisone C(H)OP or COP‐Based Therapy as Measured by Polymerase Chain Reaction Evidence of Translocation (14;18)(q32;q21)

S. Tucker, P. Mclaughlin, F. Cabanillas, 2004, Cancer journal.

Superoxide anion (O-2) production by peripheral blood monocytes in Hodgkin's disease and malignant lymphoma.

R. Perez-soler, F. Cabanillas, E. Hersh, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishment and Characterization of a New Mantle Cell Lymphoma Cell Line M-1

D. Gold, F. Cabanillas, R. Katz, 2004, Leukemia & lymphoma.

Bcl-1 gene rearrangements in B cell lymphoma.

F. Cabanillas, J. Gutterman, S. Pathak, 1988, Leukemia.

Clinical features and results of management of superior vena cava syndrome secondary to lymphoma.

R. Perez-soler, W. Velasquez, L. Fuller, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1988, Blood.

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy

J. Manning, F. Cabanillas, J. Cox, 2001, Cancer.

The radiologic assessment of the lymphoma patient from the standpoint of the clinician.

L. Fuller, F. Cabanillas, F. Cabanillas, 1990, Radiologic clinics of North America.

Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia

Susan O'Brien, Jorge Cortes, Guillermo Garcia-Manero, 2006, Cancer.

Ventricular fibrillation following AMSA. Uncomplicated retreatment following correction of hypokalemia

P. Mclaughlin, F. Cabanillas, S. Legha, 1983, Cancer.

Chromosomal abnormalities in lymphoma and their correlations with nucleic acid flow cytometry.

B. Barlogie, J. Manning, F. Cabanillas, 1986, Cancer genetics and cytogenetics.

A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.

S. Tucker, W. Velasquez, P. Mclaughlin, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells

F. Cabanillas, Woo-In Lee, Ming‐Sheng Lee, 2004, International journal of hematology.

High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.

L. Fuller, F. Cabanillas, J. Cox, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males.

B. Barlogie, W. Velasquez, F. Cabanillas, 1985, Blood.

Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma?

N. Sneige, A. Zander, J. Manning, 1987, Cancer genetics and cytogenetics.

Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.

E. Jaffe, M. Raffeld, F. Cabanillas, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Head and Neck: Editorial

J. J. Coleman, S. Ariyan, L. Delclos, 2001 .

Outcomes Using Doxorubicin-Based Chemotherapy with or without Radiotherapy for Early-Stage Peripheral T-cell Lymphomas

F. Cabanillas, J. Cox, R. Wilder, 2002, Leukemia & lymphoma.

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.

R. Kurzrock, J. Cortes, F. Cabanillas, 1995, Blood.

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

S. Jagannath, S. Tucker, W. Velasquez, 1988, Blood.

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program

M. Czuczman, P. Mclaughlin, F. Cabanillas, 2023, Journal of Clinical Oncology.

High-dose cytosine arabinoside in non-Hodgkin's lymphoma.

B. Barlogie, H. Kantarjian, W. Velasquez, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.

E J Freireich, F. Cabanillas, E. Freireich, 1987, Science.

Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphoma.

W. Velasquez, P. Mclaughlin, J. Manning, 1988, Cancer research.

High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma.

R. Kurzrock, P. Mclaughlin, F. Cabanillas, 1998, Leukemia & lymphoma.

Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.

R. Kurzrock, F. Cabanillas, F. Cabanillas, 1997, The American journal of medicine.

Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.

R. Kurzrock, F. Cabanillas, M. Talpaz, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.

F. Cabanillas, P. Allen, F. Hagemeister, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.

W. Velasquez, P. Mclaughlin, L. North, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphomas.

F. Cabanillas, M. Lee, P. Soubeyran, 1993, Blood.

Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma

S. Tucker, W. Velasquez, P. Mclaughlin, 1991 .

ABVD or equivalent regimens Hodgkin disease predicts a poorer prognosis in patients treated with BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical

T. McDonnell, G. Bonadonna, F. Cabanillas, 2013 .

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.

P. Mclaughlin, F. Cabanillas, M. Keating, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.

W. Velasquez, L. Fuller, P. Mclaughlin, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Epigenetic therapy of lymphoma using histone deacetylase inhibitors

F. Cabanillas, M. Cotto, M. V. García, 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Benign fibrous histiocytoma in Hodgkin's disease.

R. Perez-soler, F. Cabanillas, M. Luna, 1984, Cancer investigation.

Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Antibiotic Treatment of Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue: An Uncontrolled Trial

Jeffrey E. Lee, R. Winn, Yu Shen, 1999, Annals of Internal Medicine.

Hodgkin's Disease in Patients Infected with Human Immunodeficiency Virus: Frequency, Presentation and Clinical Outcome

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 2001, Leukemia & lymphoma.

Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.

W. Velasquez, L. Fuller, P. Mclaughlin, 1995, International journal of radiation oncology, biology, physics.

A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'.

P. Mclaughlin, F. Cabanillas, F. Hagemeister, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1992, Blood.

Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?

F. Cabanillas, L. Medeiros, A. Sarris, 2001, Clinical lymphoma.

Reply to I.E. Haines.

F. Cabanillas, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data.

S. Jagannath, S. Tucker, W. Velasquez, 1989, Blood.

Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).

P. Mclaughlin, F. Cabanillas, M. Keating, 1997, European journal of cancer care.

Nucleic acid flow cytometry in large cell lymphoma.

B. Barlogie, D. Johnston, F. Cabanillas, 1988, Cancer research.

Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma

S. Tucker, F. Cabanillas, J. Cox, 2002, Cancer.

Results of MIME salvage regimen for recurrent or refractory lymphoma.

W. Velasquez, L. Fuller, P. Mclaughlin, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.

S. Jagannath, W. Velasquez, P. Mclaughlin, 1988, Seminars in hematology.

Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphoma.

W. Yung, W. Velasquez, P. Mclaughlin, 1988, Journal of the National Cancer Institute.

Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients).

M. Andreeff, H. Kantarjian, F. Cabanillas, 1993, Human gene therapy.

Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.

T. McDonnell, F. Cabanillas, G. Rassidakis, 2002, American Journal of Clinical Pathology.

Surgical debulking is associated with improved survival in stage I–II diffuse large cell lymphoma

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1990, Cancer.

Combined modality therapy for stage I-II MALT lymphoma and mantle cell lymphoma.

L. Fuller, F. Cabanillas, J. Seymour, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

CHOP-Bleo plus interferon for stage IV low-grade lymphoma.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic role of serum beta 2-microglobulin in Hodgkin's disease.

L. Fuller, F. Cabanillas, P. Allen, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma

F. Cabanillas, J. Cox, R. Wilder, 2001, Cancer.

The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.

W. Velasquez, L. Fuller, P. Mclaughlin, 1988, International journal of radiation oncology, biology, physics.

Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.

F. Cabanillas, J. Cox, P. Allen, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Hematologic recovery after central lymphatic irradiation for patients with stage I–III follicular lymphoma

S. Tucker, P. Mclaughlin, F. Cabanillas, 2001, Cancer.

Diffuse large-cell lymphoma. Part I: clinical features, histology and prognosis.

F. Cabanillas, María V García-Pallas, Rafael D Betancourt-García, 2009, Puerto Rico health sciences journal.

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.

H. Kantarjian, J. Cortes, F. Cabanillas, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.

S. Jagannath, S. Tucker, F. Cabanillas, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

S. Tucker, W. Velasquez, P. Mclaughlin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease.

S. Tucker, W. Velasquez, P. Mclaughlin, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

P. Mclaughlin, J. Manning, F. Cabanillas, 2000, Bone Marrow Transplantation.

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 2001, Blood.

MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.

W. Velasquez, P. Mclaughlin, F. Cabanillas, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.

F. Cabanillas, F. Cabanillas, N. Tannir, 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.

J. Armitage, S. Jagannath, S. Tucker, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.

K. Kliche, M. Andreeff, S. Tucker, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.

P. Mclaughlin, F. Cabanillas, J. Cox, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.

H. Kantarjian, P. Mclaughlin, F. Cabanillas, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

The clinical significance of molecular response in indolent follicular lymphomas.

A. López-Guillermo, P. Mclaughlin, F. Cabanillas, 1998, Blood.

Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 1999, Blood.

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

International prognostic index‐based outcomes for diffuse large B‐cell lymphomas

S. Tucker, F. Cabanillas, L. Medeiros, 2002, Cancer.

Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.

F. Cabanillas, F. Cabanillas, R. Luthra, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.

L. Fuller, P. Mclaughlin, F. Cabanillas, 1994, Seminars in hematology.

High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma.

J. Armitage, P. Bierman, S. Jagannath, 1986, European journal of cancer & clinical oncology.

Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.

P. Mclaughlin, F. Cabanillas, F. Cabanillas, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.

L. Fuller, F. Cabanillas, F. Cabanillas, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interferon does not prolong progression-free survival after ProMACE-MOPP.

F. Cabanillas, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.